111 Price to Free Cash Flow Ratio 2018-2024 | YI
Historical price to free cash flow ratio values for 111 (YI) since 2018.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| 111 Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-03-11 | 8.10 | 5.02 | |
| 2024-09-30 | 0.76 | $1.61 | 0.47 |
| 2024-06-30 | 1.07 | $0.31 | 3.40 |
| 2024-03-31 | 1.16 | $-3.74 | 0.00 |
| 2023-12-31 | 1.55 | $-7.61 | 0.00 |
| 2023-09-30 | 2.60 | $-3.53 | 0.00 |
| 2023-06-30 | 2.46 | $-3.86 | 0.00 |
| 2023-03-31 | 2.65 | $-1.75 | 0.00 |
| 2022-12-31 | 3.02 | $-0.93 | 0.00 |
| 2022-09-30 | 2.68 | $-8.66 | 0.00 |
| 2022-06-30 | 2.06 | $-10.97 | 0.00 |
| 2022-03-31 | 2.66 | $-10.72 | 0.00 |
| 2021-12-31 | 3.50 | $-14.21 | 0.00 |
| 2021-09-30 | 6.17 | $-10.35 | 0.00 |
| 2021-06-30 | 9.09 | $-7.88 | 0.00 |
| 2021-03-31 | 13.80 | $-5.50 | 0.00 |
| 2020-12-31 | 6.95 | $-2.64 | 0.00 |
| 2020-09-30 | 6.20 | $-1.13 | 0.00 |
| 2020-06-30 | 6.35 | $-6.38 | 0.00 |
| 2020-03-31 | 6.61 | $-10.18 | 0.00 |
| 2019-12-31 | 6.73 | $-9.34 | 0.00 |
| 2019-09-30 | 4.87 | $-12.89 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.072B | $2.105B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.709B | 54.09 |
| Hims & Hers Health (HIMS) | United States | $11.210B | 183.25 |
| Tempus AI (TEM) | United States | $10.954B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.532B | 107.78 |
| IRhythm Technologies (IRTC) | United States | $3.734B | 0.00 |
| Privia Health (PRVA) | United States | $2.941B | 245.10 |
| Enovis (ENOV) | United States | $2.475B | 16.49 |
| Clover Health Investments (CLOV) | United States | $2.095B | 0.00 |
| Azenta (AZTA) | United States | $2.083B | 96.98 |
| Omnicell (OMCL) | United States | $1.845B | 40.23 |
| Schrodinger (SDGR) | United States | $1.580B | 0.00 |
| Phreesia (PHR) | United States | $1.577B | 0.00 |
| 10x Genomics (TXG) | United States | $1.381B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.859B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.512B | 0.00 |
| Standard BioTools (LAB) | United States | $0.495B | 0.00 |
| Talkspace (TALK) | United States | $0.481B | 285.00 |
| TruBridge (TBRG) | United States | $0.423B | 123.26 |
| Nyxoah SA (NYXH) | Belgium | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.352B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.305B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.257B | 0.00 |
| American Well (AMWL) | United States | $0.174B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.085B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| CareCloud (CCLD) | United States | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |